Overview

PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram

Status:
Completed
Trial end date:
2009-02-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure a particular protein in the brain called the phosphodiesterase by using the imaging techniques of positron emission tomography (PET) and magnetic resonance imaging (MRI). ...
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)
Treatments:
Phosphodiesterase 4 Inhibitors
Rolipram